Drug Development Work Breakdown Structure
This is a practical guide to building a work breakdown structure for a drug development project — a deliverable-oriented decomposition of the whole scope into manageable work packages, adapted to the realities of developing a pharmaceutical product through regulatory stages.
What a Work Breakdown Structure is
A work breakdown structure is a deliverable-oriented decomposition of the whole scope into manageable work packages. For the full concept and how it works in general, see Work Breakdown Structure. On a drug development project it plays the same role, tuned to this kind of work.
Why it matters for a Drug Development project
Drug Development projects live or die on developing a pharmaceutical product through regulatory stages. A well-built work breakdown structure gives the team a shared, explicit reference for exactly that — reducing ambiguity, aligning stakeholders, and making problems visible early enough to act. Skipping it, or doing it generically, is how drug development projects drift into avoidable delay and cost.
What to include
- Top-level deliverables
- Sub-deliverables
- Work packages (8–80 hours)
- WBS numbering
- WBS dictionary entries
Drug Development-specific considerations
Tailor the work breakdown structure to the risks that most often derail drug development projects:
- Regulatory approval delays
- Trial/validation failures
- Strict GxP compliance
Example
On a real drug development project, the work breakdown structure would be shaped by developing a pharmaceutical product through regulatory stages. In particular, it should explicitly account for the project’s biggest risks — regulatory approval delays, trial/validation failures, strict GxP compliance — rather than treating them as afterthoughts.